rs397515442

Variant summary

Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PP3PP5_Very_Strong

The NM_018972.4(GDAP1):ā€‹c.368A>Gā€‹(p.His123Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā˜…ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 6.8e-7 ( 0 hom. )

Consequence

GDAP1
NM_018972.4 missense

Scores

9
4
6

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:5U:2O:1

Conservation

PhyloP100: 8.89
Variant links:
Genes affected
GDAP1 (HGNC:15968): (ganglioside induced differentiation associated protein 1) This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 13 ACMG points.

PM1
In a helix (size 11) in uniprot entity GDAP1_HUMAN there are 6 pathogenic changes around while only 0 benign (100%) in NM_018972.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.796
PP5
Variant 8-74360194-A-G is Pathogenic according to our data. Variant chr8-74360194-A-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 50558.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-74360194-A-G is described in Lovd as [Pathogenic]. Variant chr8-74360194-A-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GDAP1NM_018972.4 linkuse as main transcriptc.368A>G p.His123Arg missense_variant 3/6 ENST00000220822.12 NP_061845.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GDAP1ENST00000220822.12 linkuse as main transcriptc.368A>G p.His123Arg missense_variant 3/61 NM_018972.4 ENSP00000220822 P3Q8TB36-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461398
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
727070
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5Uncertain:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease axonal type 2K Pathogenic:2Uncertain:1
Pathogenic, no assertion criteria providedliterature onlyOMIMAug 09, 2011- -
Uncertain significance, no assertion criteria providedliterature onlyInherited Neuropathy Consortium Ii, University Of MiamiJan 06, 2016- -
Pathogenic, criteria provided, single submitterresearchCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterMar 25, 2024- -
not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingGeneDxAug 18, 2016The H123R pathogenic variant in the GDAP1 gene has been reported previously in multiple unrelatedfamilies with autosomal dominant Charcot-Marie-Tooth (CMT) disease (Zimon et al., 2011; Auranenet al., 2013; Pezzini et al., 2016) . The H123R variant has been determined to be a founder mutationin the Finnish population and accounts for up to 14% of Finnish individuals with a clinical diagnosis ofCMT2 (Auranen et al., 2013). The H123R variant was not observed in approximately 6500individuals of European and African American ancestry in the NHLBI Exome Sequencing Project,indicating it is not a common benign variant in these populations. This conservative amino acidsubstitution occurs at a position that is conserved in mammals and in silico analysis is inconsistent inits predictions as to whether or not the variant is damaging to the protein structure/function. Missensevariants in nearby residues (R120G, R120W, R120Q, Q122K, D129H) have been reported in theHuman Gene Mutation Database in association with CMT (Stenson et al., 2014), supporting thefunctional importance of this region of the protein. We interpret H123R as a pathogenic variant. -
Likely pathogenic, criteria provided, single submitterclinical testingClinical Genetics and Genomics, Karolinska University HospitalNov 25, 2014- -
Charcot-Marie-Tooth disease Uncertain:1Other:1
not provided, no classification providedliterature onlyGeneReviews-- -
Uncertain significance, no assertion criteria providedresearchGenesis Genome DatabaseAug 14, 2019- -
Charcot-Marie-Tooth disease type 4A Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 30, 2023This variant is not present in population databases (gnomAD no frequency). This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 123 of the GDAP1 protein (p.His123Arg). This missense change has been observed in individual(s) with autosomal dominant Charcot-Marie-Tooth disease and is associated with reduced penetrance (PMID: 21753178, 23456260, 23963299, 26525999). In at least one individual the variant was observed to be de novo. It is commonly reported in individuals of Finnish ancestry (PMID: 21753178, 23456260, 23963299, 26525999). ClinVar contains an entry for this variant (Variation ID: 50558). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects GDAP1 function (PMID: 28220846). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.68
BayesDel_addAF
Pathogenic
0.50
D
BayesDel_noAF
Pathogenic
0.48
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Benign
0.14
T;.
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Pathogenic
0.31
D
MetaRNN
Pathogenic
0.80
D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Benign
1.9
L;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-1.6
N;N
REVEL
Pathogenic
0.81
Sift
Benign
0.083
T;T
Sift4G
Benign
0.080
T;T
Polyphen
0.80
P;.
Vest4
0.93
MutPred
0.54
Gain of methylation at H123 (P = 0.0345);.;
MVP
1.0
MPC
1.4
ClinPred
0.90
D
GERP RS
5.5
Varity_R
0.28
gMVP
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs397515442; hg19: chr8-75272429; API